The cannabis terpenes β-caryophyllene and α-humulene reduced neuropathic pain and “significantly inhibited” tumor growth. The post Cannabis Terpenes Exhibit Anti-Cancer Effects in Preclinical Trial appeared first on NORML.
Delaware moves a step closer to recreational marijuana sales
Delaware lawmakers moved the state a step closer to recreational marijuana sales this week, when a state Senate committee gave the thumbs up to a bill from the state House that would allow the existing six medical marijuana companies to launch adult-use sales. The bill is aimed at getting the …
Alabama’s medical marijuana program mired in more delays
Alabama’s medical marijuana program remains stalled three years since its creation, amid ongoing legal battles over business licenses. The Alabama Court of Civil Appeals issued two rulings last week that could reshape the dispute, according to local media reports. One decision ordered the dismissal of a consolidated “master” case against …
New York’s OCM distracted with over 20 lawsuits
If New York cannabis applicants are wondering why the licensing process is slow, they just need to look at the number of lawsuits facing the state’s Office of Cannabis Management. At the recent New York Cannabis Law Conference, Rudick Law Group lawyers Fatima Afia and Lauren Rudick counted at least …